Date: 1300-1730 Wednesday 16 November 2011

Venue: One Great George Street Conference Centre, London

Introduction

BHIVA has set up the BHIVA Hepatitis Working Group which brings together those directly involved in the care of HIV-infected patients co-infected with hepatitis B or C, as well as those who have a clinical or research interest in the epidemiology, natural history or basic science of viral hepatitis.

This Working Group conducted their fourth annual conference in London on Wednesday 16 November 2011. The half-day conference was followed by the BHIVA Autumn Conference on 17–18 November 2011, just around the corner, at the Queen Elizabeth II Conference Centre.

Final Programme


Download Final Programme

Presentations

Plenary Session 1

Didanosine and the liver: diagnosis, monitoring and treatment of non-cirrhotic portal hypertension
Dr Sanjay Bhagani, Royal Free Hospital, London

IL28b and other new predictors of success
Dr Andri Rauch, University Hospital of Bern, Switzerland

Plenary Session 2

New drugs for hepatitis C in the HIV co-infected (presentation not available)
Professor Geoff Dusheiko, Royal Free Hospital, London

When will we have an interferon-sparing approach to hepatitis? (presentation not available)
Dr Kosh Agarwal, King’s College, London